C1q and central nervous system disorders

被引:22
|
作者
Zhang, Wenjie [1 ,2 ]
Chen, Yuan [3 ]
Pei, Hui [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Emergency, Intens Care Unit, Zhengzhou, Peoples R China
[2] Xingyang Sishui Cent Hlth Ctr, Dept Gen Practice, Zhengzhou, Peoples R China
[3] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
关键词
c1q; central nervous system; neurodevelopment; degenerative diseases; inflammatory diseases; glioma; GUILLAIN-BARRE-SYNDROME; TRAUMATIC BRAIN-INJURY; COMPLEMENT PROTEIN C1Q; MOUSE MODEL; SPINAL-CORD; COGNITIVE IMPAIRMENT; PARKINSONS-DISEASE; PATHWAY ACTIVATION; CLASSICAL PATHWAY; UP-REGULATION;
D O I
10.3389/fimmu.2023.1145649
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
C1q is a crucial component of the complement system, which is activated through the classical pathway to perform non-specific immune functions, serving as the first line of defense against pathogens. C1q can also bind to specific receptors to carry out immune and other functions, playing a vital role in maintaining immune homeostasis and normal physiological functions. In the developing central nervous system (CNS), C1q functions in synapse formation and pruning, serving as a key player in the development and homeostasis of neuronal networks in the CNS. C1q has a close relationship with microglia and astrocytes, and under their influence, C1q may contribute to the development of CNS disorders. Furthermore, C1q can also have independent effects on neurological disorders, producing either beneficial or detrimental outcomes. Most of the evidence for these functions comes from animal models, with some also from human specimen studies. C1q is now emerging as a promising target for the treatment of a variety of diseases, and clinical trials are already underway for CNS disorders. This article highlights the role of C1q in CNS diseases, offering new directions for the diagnosis and treatment of these conditions.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] C1q is essential for myelination in the central nervous system (CNS)
    Yu, Qiang
    Zhang, Nan
    Guan, Teng
    Guo, Ying
    Marzban, Hassan
    Lindsey, Benjamin
    Kong, Jiming
    ISCIENCE, 2023, 26 (12)
  • [2] Morphological Representation of C1q in the Aging Central Nervous System
    Rupprecht, Christian
    Sarker, Rim S. J.
    Rammes, Gerhard
    PHARMACOPSYCHIATRY, 2022, 55 (04) : 203 - 210
  • [3] Zinc and Central Nervous System Disorders
    Wang, Bangqi
    Fang, Tianshu
    Chen, Hongping
    NUTRIENTS, 2023, 15 (09)
  • [4] Autophagy in the Central Nervous System: Implications for Neurodegenerative Disorders
    Xilouri, Maria
    Stefanis, Leonidas
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2010, 9 (06) : 701 - 719
  • [5] Glutamate transporter-1 (GLT-1): a potential therapeutic target for the treatment of central nervous system diseases and disorders
    Abou-Gharbia, M.
    Blass, B.
    Childers, W.
    Ramanjulu, M.
    Melenski, E.
    DRUGS OF THE FUTURE, 2017, 42 (08) : 489 - 509
  • [6] A review for the pharmacological effect of lycopene in central nervous system disorders
    Chen, Dongjian
    Huang, Chao
    Chen, Zhuo
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 111 : 791 - 801
  • [7] Gut Microbiota and Disorders of the Central Nervous System
    Vuotto, Claudia
    Battistini, Luca
    Caltagirone, Carlo
    Borsellino, Giovanna
    NEUROSCIENTIST, 2020, 26 (5-6) : 487 - 502
  • [8] The role of GluA 1 in central nervous system disorders
    Zhang, Jingli
    Abdullah, Jafri Malin
    REVIEWS IN THE NEUROSCIENCES, 2013, 24 (05) : 499 - 505
  • [9] Protective and Regenerative Roles of T Cells in Central Nervous System Disorders
    Evans, Frances L.
    Dittmer, Marie
    Denise, Alerie G. de la Fuente
    Fitzgerald, Denise C.
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [10] The lymphatic system: a therapeutic target for central nervous system disorders
    Xu, Jia-Qi
    Liu, Qian-Qi
    Huang, Sheng-Yuan
    Duan, Chun-Yue
    Lu, Hong-Bin
    Cao, Yong
    Hu, Jian-Zhong
    NEURAL REGENERATION RESEARCH, 2023, 18 (06) : 1249 - 1256